Abstract FR503: Systolic vs Diastolic Orthostatic Hypotension: Relationship to Cardiovascular Outcomes and Adverse Events Among Hypertensive Patients
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.fr503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Mark Ruscin und 3 weiteren Autor:innen.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
Orthostatic hypotension (OH) remains a concern in patients treated for hypertension, particularly among older patients. However, it is not well established whether drops in systolic (SOH), diastolic (DOH), or both (SDOH) blood pressure values upon standing carry distinct risks for cardiovascular (CV) outcomes or treatment-related adverse events.
Aim
To determine if SOH, DOH, or SDOH is associated with greater risk for cardiovascular outcomes or serious adverse events (SAEs), as compared to patients without OH, among middle-aged and older adults treated for hypertension.
Methods
Data from the Systolic Blood Pressure Intervention Trial (SPRINT) was used for the analysis. Baseline BP measurements were used to identify participants with and without OH (SBP drop of ≥ 20 mmHg [SOH], DBP drop of ≥ 10 mmHg [DOH], or both [SDOH]). We evaluated the association of SOH, DOH, and SDOH to cardiovascular outcomes (MI, non-MI ACS, stroke, HF, CV death) and serious adverse events using Firth’s penalized likelihood Cox proportional hazards regression models, adjusting for treatment arm, age, race, sex, BMI, and prior cardiovascular disease history.
Results
The analysis included 9,246 patients (mean age 68±9 years; 35% female; 30% Black; 20% with prior CVD). Baseline OH was present in 571 (6.6%) patients; 286 with SOH (50.1%); 193 with DOH (33.8%); and 92 with SDOH (16.1%). For the composite CV outcome, DOH and SDOH were significantly associated with increased risk of CV events, HR 2.17 (95% CI 1.38 - 3.24; P =0.001) and 2.07 (95% CI 1.05 - 3.62; P =0.036), respectively; however, SOH was not, HR 1.43 (95% CI 0.95 - 2.07; P =0.079). Individually, DOH was associated with stroke events, HR 3.46 (95% CI 1.59 - 6.55; P =0.003), and SOH was associated with non-MI ACS, HR 2.66 (95% CI 1.06 - 5.57; P =0.037). With regard to SAEs, patients with DOH or SDOH were more likely to experience any SAE, HR 1.29 (95%CI 1.03 - 1.60; P =0.024) and 1.45 (95% CI 1.06 - 1.91; P =0.019), respectively. Combining SAEs associated with fall risk (hypotension, bradycardia, syncope or injurious falls), patients with SOH, but not DOH or SDOH, had higher fall-risk SAE, HR 1.44 (95% CI 1.09 - 1.86; P =0.01).
Conclusion
Presence of DOH (DOH or SDOH) was associated with greater cardiovascular risks and treatment-related SAEs; whereas SOH was associated with greater fall-related risks. The presence of OH and distinguishing between specific OH phenotypes may have clinical relevance among patients treated for hypertension.
Zitieren
APA
Ruscin, M., Buhnerkempe, M., Prakash, V., & Flack, J. M. (2026). Abstract FR503: Systolic vs Diastolic Orthostatic Hypotension: Relationship to Cardiovascular Outcomes and Adverse Events Among Hypertensive Patients. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.fr503
Vancouver
Ruscin M, Buhnerkempe M, Prakash V, Flack JM. Abstract FR503: Systolic vs Diastolic Orthostatic Hypotension: Relationship to Cardiovascular Outcomes and Adverse Events Among Hypertensive Patients. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.fr503
BibTeX
@article{Ruscin2026,
author = {Ruscin, Mark and Buhnerkempe, Michael and Prakash, Vivek and Flack, John M},
title = {Abstract FR503: Systolic vs Diastolic Orthostatic Hypotension: Relationship to Cardiovascular Outcomes and Adverse Events Among Hypertensive Patients},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.fr503}
}
EUVIMED